CHICAGO -- Bobby Mukkamala, MD, credits NIH-funded research for the targeted therapy that keeps his brain tumor at bay. But last November, the then-president-elect of the American Medical Association (AMA) wasn't sure he'd live long enough to attend the organization's annual June meeting, much less get sworn in to his elected office.

Mukkamala, an otolaryngologist from Flint, Michigan, was diagnosed with an 8-cm tumor in his brain's left temporal lobe shorty after the AMA's House of Delegates interim meeting in Orlando, Florida, during which he experienced expressive aphasia while giving an update to his fellow members.

Thankfully, Mukkamala did make this month's meeting , and was officially sworn in Tuesday night as the AMA's 180th president. He used his inaugural address as an oppo

See Full Page